Researchers at Harvard University and the Wyss Institute are developing an injectable biomaterial that forms a tiny scaffold in the body which can be used to re-program cells and trigger an immune response to fight cancer and infectious diseases. Ben Gruber Reports.
02:49
00:01
01:33
02:47
01:29
02:28
01:23
01:25
01:46
02:28
01:41
02:00
01:08
02:15
01:52
01:17
01:22
01:52
02:54
01:15